BR
Biswa Ranjan Dash
About Biswa Ranjan Dash
Data last updated:
Biswa Ranjan Dash is a Director at Fosen Pharmaceuticals Private Limited (since 2020). The companies operate in Business Services and Chemicals. Fosen Pharmaceuticals Private Limited reported revenue of ₹18.6 Lakh (FY 2025). Earlier, Biswa Ranjan Dash was a Managing Director at Senberk Pharmaceuticals Private Limited (2015–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2020 | 2017 | ₹18.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 20 Jan 2015 | 2015 | ₹32.5 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Biswa Ranjan Dash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alakananda Samantaray | 09468920 | Fosen Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Biswa Ranjan Dash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biswa Ranjan Dash
Biswa Ranjan Dash currently holds 1 directorship: Fosen Pharmaceuticals Private Limited (Director, since 17 Feb 2020, revenue ₹18.6 Lakh (FY 2025)).
Biswa Ranjan Dash was first appointed on 20 Jan 2015 as Managing Director at Senberk Pharmaceuticals Private Limited. The most recent appointment on record is 17 Feb 2020 at Fosen Pharmaceuticals Private Limited.
Biswa Ranjan Dash held 1 earlier board appointment: Senberk Pharmaceuticals Private Limited (Managing Director, 20 Jan 2015 to 30 Mar 2025).
The current boards of Biswa Ranjan Dash's companies include Alakananda Samantaray (Fosen Pharmaceuticals Private Limited).